​

Exicure (XCUR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

XCUR Stock Forecast

Exicure stock forecast is as follows: an average price target of $12.00 (represents a -23.27% downside from XCUR’s last price of $15.64) and

XCUR Price Target

Exicure Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 26, 2022Keay NakaeChardan Capital$12.00$4.94142.72%-23.27%

The latest Exicure stock forecast, released on Jan 26, 2022 by Keay Nakae from Chardan Capital, set a price target of $12.00, which represents a 142.72% increase from the stock price at the time of the forecast ($4.94), and a -23.27% decrease from XCUR last price ($15.64).

Exicure Price Target by Period

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$15.64$15.64$15.64
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Exicure stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Exicure's last price of $15.64. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Exicure Financial Forecast

Exicure Revenue Forecast

Sep 24Jun 24Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Jun 18
Revenue---$21.77M$2.02M$2.47M$2.56M$3.68$-3.68M$79.00K$997.00K$140.00K$2.44M$4.85M$9.18M$310.00K$527.00K$434.00K$25.00K$19.00K
Avg Forecast--$3.90M$3.90M$3.90M$4.10M$4.30M$3.50M$6.99M$1.55M$1.64M$3.09M$2.37M$1.73M$1.43M$100.00K$250.00K$300.00K$100.00K$16.76K
High Forecast--$3.90M$6.62M$3.90M$4.10M$4.30M$3.50M$6.99M$1.55M$1.64M$3.09M$2.37M$1.73M$1.43M$100.00K$250.00K$300.00K$100.00K$20.12K
Low Forecast--$3.90M$1.18M$3.90M$4.10M$4.30M$3.50M$6.99M$1.55M$1.64M$3.09M$2.37M$1.73M$1.43M$100.00K$250.00K$300.00K$100.00K$13.41K
# Analysts--111111111111010999920
Surprise %---5.58%0.52%0.60%0.60%0.00%-0.53%0.05%0.61%0.05%1.03%2.80%6.41%3.10%2.11%1.45%0.25%1.13%

Exicure's average Quarter revenue forecast for Mar 23 based on 1 analysts is $3.90M, with a low forecast of $3.90M, and a high forecast of $3.90M. XCUR's average Quarter revenue forecast represents a -82.09% decrease compared to the company's last Quarter revenue of $21.77M (Dec 22).

Exicure EBITDA Forecast

Sep 24Jun 24Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Jun 18
# Analysts--111111111111010999920
EBITDA--$-4.42M$19.04M$-4.74M$-7.02M$-7.28M$460.94K$-23.54M$-13.37M$-11.64M$-11.83M$-8.12M$-4.12M$1.43M$-9.57M$-5.27M$-4.93M$-5.02M$-6.57M
Avg Forecast--$2.11K$2.11K$-15.02K$-15.79K$-16.56K$-13.48K$-26.91K$-5.98K$-9.70M$-11.90K$-9.11K$-6.67K$-5.52K$-385.00$-962.00$-1.16K$-5.02M$-5.69M
High Forecast--$2.11K$3.58K$-15.02K$-15.79K$-16.56K$-13.48K$-26.91K$-5.98K$-7.76M$-11.90K$-9.11K$-6.67K$-5.52K$-385.00$-962.00$-1.16K$-4.01M$-4.55M
Low Forecast--$2.11K$641.00$-15.02K$-15.79K$-16.56K$-13.48K$-26.91K$-5.98K$-11.64M$-11.90K$-9.11K$-6.67K$-5.52K$-385.00$-962.00$-1.16K$-6.02M$-6.83M
Surprise %---2096.68%9025.59%315.44%444.86%439.93%-34.20%874.76%2237.04%1.20%994.45%890.82%617.92%-258.38%24867.53%5481.29%4268.40%1.00%1.15%

1 analysts predict XCUR's average Quarter EBITDA for Mar 23 to be $2.11K, with a high of $2.11K and a low of $2.11K. This is -99.99% lower than Exicure's previous annual EBITDA (Dec 22) of $19.04M.

Exicure Net Income Forecast

Sep 24Jun 24Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Jun 18
# Analysts--111111111111010999920
Net Income$-1.09M-$-3.96M$18.40M$-5.12M$12.99K$-611.01K$-65.79$-23.53M$-14.27M$-12.48M$-12.69M$-8.82M$-4.31M$1.15M$-9.98M$-5.82M$-5.22M$-5.29M$-6.83M
Avg Forecast$2.93M$11.61M$-1.80M$-1.80M$-38.93M$-51.91M$-90.84M$-181.67M$-120.03M$-181.67M$-10.40M$-134.96M$-120.03M$-110.30M$2.19M$-113.55M$-103.81M$-168.70M$-5.29M$-5.91M
High Forecast$2.93M$11.61M$-1.80M$-1.80M$-38.93M$-51.91M$-90.84M$-181.67M$-120.03M$-181.67M$-8.32M$-134.96M$-120.03M$-110.30M$2.62M$-113.55M$-103.81M$-168.70M$-4.23M$-4.73M
Low Forecast$2.93M$11.61M$-1.80M$-1.80M$-38.93M$-51.91M$-90.84M$-181.67M$-120.03M$-181.67M$-12.48M$-134.96M$-120.03M$-110.30M$1.75M$-113.55M$-103.81M$-168.70M$-6.34M$-7.10M
Surprise %-0.37%-2.19%-10.19%0.13%-0.00%0.01%0.00%0.20%0.08%1.20%0.09%0.07%0.04%0.53%0.09%0.06%0.03%1.00%1.15%

Exicure's average Quarter net income forecast for Mar 23 is $-1.80M, with a range of $-1.80M to $-1.80M. XCUR's average Quarter net income forecast represents a -109.81% decrease compared to the company's last Quarter net income of $18.40M (Dec 22).

Exicure SG&A Forecast

Sep 24Jun 24Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Jun 18
# Analysts--111111111111010999920
SG&A$1.43M-$2.56M$2.11M$2.42M$3.21M$3.16M$10.14$2.95M$3.10M$2.89M$2.73M$2.42M$2.23M$2.57M$2.15M$2.23M$1.99M$2.21M$1.99M
Avg Forecast--$-14.43M$-14.43M$-14.43M$-15.17M$-15.91M$-12.95M$-25.86M$-5.75M$-6.08M$-11.44M$-8.76M$-6.41M$-5.30M$-370.06K$-925.16K$-1.11M$-370.06K$-62.04K
High Forecast--$-14.43M$-4.38M$-14.43M$-15.17M$-15.91M$-12.95M$-25.86M$-5.75M$-6.08M$-11.44M$-8.76M$-6.41M$-5.30M$-370.06K$-925.16K$-1.11M$-370.06K$-49.63K
Low Forecast--$-14.43M$-24.48M$-14.43M$-15.17M$-15.91M$-12.95M$-25.86M$-5.75M$-6.08M$-11.44M$-8.76M$-6.41M$-5.30M$-370.06K$-925.16K$-1.11M$-370.06K$-74.44K
Surprise %---0.18%-0.15%-0.17%-0.21%-0.20%-0.00%-0.11%-0.54%-0.48%-0.24%-0.28%-0.35%-0.49%-5.82%-2.41%-1.79%-5.97%-32.05%

Exicure's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to XCUR last annual SG&A of $1.43M (Sep 24).

Exicure EPS Forecast

Sep 24Jun 24Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Jun 18
# Analysts--111111111111010999920
EPS$-0.06-$-0.63$0.56$-1.03-$-0.15-$-8.01$-4.86$-4.26$-4.33$-3.03$-1.48$0.39$-3.39$-2.70$-3.53$-3.58$-5.19
Avg Forecast$1.54$1.34$-0.95$-0.95$-4.50$-6.00$-10.50$-21.00$-13.88$-21.00$-18.60$-15.60$-13.88$-12.75$-13.50$-13.13$-12.00$-19.50$-18.00$-0.13
High Forecast$1.54$1.34$-0.95$-0.95$-4.50$-6.00$-10.50$-21.00$-13.88$-21.00$-18.60$-15.60$-13.88$-12.75$-13.50$-13.13$-12.00$-19.50$-18.00$-0.10
Low Forecast$1.54$1.34$-0.95$-0.95$-4.50$-6.00$-10.50$-21.00$-13.88$-21.00$-18.60$-15.60$-13.88$-12.75$-13.50$-13.13$-12.00$-19.50$-18.00$-0.16
Surprise %-0.04%-0.66%-0.59%0.23%-0.00%0.01%-0.58%0.23%0.23%0.28%0.22%0.12%-0.03%0.26%0.22%0.18%0.20%39.92%

According to 1 Wall Street analysts, Exicure's projected average Quarter EPS for Mar 23 is $-0.95, with a low estimate of $-0.95 and a high estimate of $-0.95. This represents a -269.64% decrease compared to XCUR previous annual EPS of $0.56 (Dec 22).

Exicure Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
MISTMilestone Pharmaceuticals$1.82$10.00449.45%Buy
SCPHscPharmaceuticals$3.25$13.00300.00%Buy
PMVPPMV Pharmaceuticals$1.52$6.00294.74%Buy
LUMOLumos Pharma$4.34$16.50280.18%Buy
CYCCCyclacel Pharmaceuticals$0.37$1.00170.27%Buy
DMACDiaMedica Therapeutics$5.20$8.5063.46%Buy
MCRBSeres Therapeutics$0.88$1.2542.05%Buy
IKNAIkena Oncology$1.62$1.33-17.90%Buy
XCURExicure$18.53$12.00-35.24%

XCUR Forecast FAQ

Will Exicure stock go up soon?

According to Wall Street analysts' prediction for XCUR stock, the company can go down by -23.27% (from the last price of $15.64 to the average price target of $12), down by -23.27% based on the highest stock price target, and down by -23.27% based on the lowest stock price target.

Can Exicure stock reach $20?

XCUR's average twelve months analyst stock price target of $12 does not support the claim that Exicure can reach $20 in the near future.

What are Exicure's analysts' financial forecasts?

Exicure's analysts financial forecasts for the fiscal year (Dec 2021) are as follows: average revenue is $13.69M (high $13.69M, low $13.69M), average EBITDA is $-9.749M (high $-7.808M, low $-11.689M), average net income is $-494M (high $-492M, low $-496M), average SG&A $-50.644M (high $-50.644M, low $-50.644M), and average EPS is $-74.475 (high $-74.475, low $-74.475).

Did the XCUR's actual financial results beat the analysts' financial forecasts?

Based on Exicure's last annual report (Dec 2022), the company's revenue was $28.83M, beating the average analysts forecast of $16.2M by 77.94%. Apple's EBITDA was $-1.856M, beating the average prediction of $-45.251K by 4001.57%. The company's net income was $-2.582M, missing the average estimation of $-183M by -98.59%. Apple's SG&A was $10.89M, missing the average forecast of $-59.951M by -118.16%. Lastly, the company's EPS was $-0.56, missing the average prediction of $-21.95 by -97.45%. In terms of the last quarterly report (Dec 2022), Exicure's revenue was $21.77M, beating the average analysts' forecast of $3.9M by 458.31%. The company's EBITDA was $19.04M, beating the average prediction of $2.11K by 902459.24%. Exicure's net income was $18.4M, missing the average estimation of $-1.804M by -1119.48%. The company's SG&A was $2.11M, missing the average forecast of $-14.433M by -114.60%. Lastly, the company's EPS was $0.56, missing the average prediction of $-0.95 by -158.95%